Institute for Rare and Neglected Diseases Drug Discovery Information

iRND3 is a non-profit organization discovering innovative, affordable and quality medicines that address unment medical needs for rare and neglected diseases. Our novel approach to drug discovery is based on optimization of binding kinetics for appropriately selected targets. By measuring biochemical efficiency we provide an early metric for predicting the success of candidate medicines during the development process. This novel paradigm for drug discovery is specifically designed for rare and neglected diseases.